Response to Siegelet al.

  • Alan V. Boddy


Response Site Drug Clearance Arterial Supply Regional Drug Hepatic Drug 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


  1. 1.
    R. A. Siegel, R. D. MacGregor, and C. A. Hunt. Comparison and critique of two models for regional drug delivery.J. Pharmacokin. Biopharm. 19:363–373 (1991).CrossRefGoogle Scholar
  2. 2.
    A. V. Boddy, and L. J. Aarons. Application of a linear recirculation model to drug targeting.J. Pharmacokin. Biopharm. 19:355–362 (1991).CrossRefGoogle Scholar
  3. 3.
    C. A. Hunt, R. D. MacGregor, and R. A. Siegel. Engineering targetedin vivo drug delivery. I. The physiological and physicochemical principles governing opportunities and limitations.Pharm. Res. 3:333–344 (1986).PubMedCrossRefGoogle Scholar
  4. 4.
    A. V. Boddy, K. Zhang, F. Lepage, F. Tombret, J. G. Slatterj, T.A. Baillie, and R. H. Levy.In vitro andin vivo investigations of dihydropyridine-based chemical delivery systems for anticonvulsants.Pharm. Res. 8:690–697 (1991).PubMedCrossRefGoogle Scholar

Copyright information

© Plenum Publishing Corporation 1991

Authors and Affiliations

  • Alan V. Boddy
    • 1
  1. 1.Department of PharmaceuticsUniversity of WashingtonSeattle

Personalised recommendations